ATE295423T1 - Phosphodiesterase 8 - Google Patents

Phosphodiesterase 8

Info

Publication number: ATE295423T1
Authority: AT; Austria
Prior art keywords: polypeptides; polynucleotides; pde8; expression constructs; phosphodiesterase
Prior art date: 1997-10-16

Application number

AT98953651T

Other languages

English (en)

Inventor

Kate Loughney

Original Assignee

Icos Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-16

Filing date

1998-10-16

Publication date

2005-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25491965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE295423(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-10-16 Application filed by Icos Corp filed Critical Icos Corp

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE295423T1 publication Critical patent/ATE295423T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Cereal-Derived Products (AREA)

AT98953651T 1997-10-16 1998-10-16 Phosphodiesterase 8 ATE295423T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/951,648 US5932465A (en)	1997-10-16	1997-10-16	Phosphodiesterase 8A
PCT/US1998/021956 WO1999019495A1 (en)	1997-10-16	1998-10-16	Phosphodiesterase 8a

Publications (1)

Publication Number	Publication Date
ATE295423T1 true ATE295423T1 (de)	2005-05-15

Family

ID=25491965

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98953651T ATE295423T1 (de)	1997-10-16	1998-10-16	Phosphodiesterase 8

Country Status (14)

Country	Link
US (4)	US5932465A (de)
EP (2)	EP1571216A3 (de)
JP (1)	JP2001512327A (de)
CN (2)	CN1229499C (de)
AT (1)	ATE295423T1 (de)
AU (1)	AU1097499A (de)
BR (1)	BR9806318A (de)
CA (1)	CA2275135A1 (de)
DE (1)	DE69830143T2 (de)
ES (1)	ES2245485T3 (de)
IL (3)	IL130287A0 (de)
NO (1)	NO992916L (de)
RU (2)	RU2272841C2 (de)
WO (1)	WO1999019495A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2238283C (en)	1997-05-30	2002-08-20	Cell Pathways, Inc.	Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US5858694A (en) *	1997-05-30	1999-01-12	Cell Pathways, Inc.	Method for identifying compounds for inhibition of cancerous lesions
EP0967284A1 (de) *	1998-05-28	1999-12-29	Pfizer Limited	Phosphodiesterasen
US6130053A (en) *	1999-08-03	2000-10-10	Cell Pathways, Inc.	Method for selecting compounds for inhibition of neoplastic lesions
GB9922125D0 (en)	1999-09-17	1999-11-17	Pfizer Ltd	Phosphodiesterase enzymes
US6673564B2 (en) *	1999-10-18	2004-01-06	Millennium Pharmaceuticals, Inc.	Methods for using 22045, a human cyclic nucleotide phosphodiesterase
CN1297049A (zh) *	1999-11-23	2001-05-30	上海博容基因开发有限公司	一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
US6555547B1 (en)	2000-02-28	2003-04-29	Cell Pathways, Inc.	Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en)	2000-03-03	2003-05-27	Cell Pathways, Inc	Method for screening compounds for the treatment of neoplasia
CN1312381A (zh) *	2000-03-07	2001-09-12	上海博德基因开发有限公司	一种新的多肽——人环腺苷酸磷酸二脂酶13和编码这种多肽的多核苷酸
DE60130565D1 (de) *	2000-09-12	2007-10-31	Univ Bern	Pde8a und seine verwendung
JP4999255B2 (ja) *	2001-07-10	2012-08-15	レイクウッド−アメディックス，インコーポレーテッド	オリゴヌクレオチド含有薬理学的組成物およびその使用
AU2003276187A1 (en) *	2002-11-08	2004-06-07	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)
AU2005223847A1 (en) *	2004-03-19	2005-09-29	Yale University	Detection, isolation and uses of renalase (Monoamine Oxidase C)
AU2006304787A1 (en)	2005-10-21	2007-04-26	Braincells, Inc.	Modulation of neurogenesis by PDE inhibition
EP1951291A4 (de)	2005-11-21	2012-04-04	Univ Yale	Verfahren zur regulierung von renalase (monoaminoxidase c)
CN101917992A (zh) *	2007-03-27	2010-12-15	奥默罗斯公司	用于治疗运动障碍的pde7抑制剂的用途
KR101778036B1 (ko) *	2009-05-12	2017-09-14	코닌클리케 필립스 엔.브이.	전립선암 마커로서의 포스포디에스테라제 4ｄ7
CN103443128B (zh) *	2011-03-11	2017-11-24	阿雷克森制药公司	npp1融合蛋白
RU2760943C2 (ru) *	2011-09-15	2021-12-01	Алексион Фармасьютикалз, Инк.	Гибридные белки NPP1
US20150119399A1 (en)	2012-01-10	2015-04-30	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use
WO2019067502A1 (en)	2017-09-27	2019-04-04	Alexion Pharmaceuticals, Inc.	METHODS FOR IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING RECOMBINANT ECTO-NUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2128227C1 (ru) *	1989-12-22	1999-03-27	Апплайд Резеч Системз АРС Холдинг Н.В. (NL) (Антильские острова)	Способ активации транскрипционно-молчащего гена
WO1992020808A1 (en) *	1991-05-15	1992-11-26	Cell Genesys, Inc.	Genomic modifications with homologous dna targeting
TW402639B (en) *	1992-12-03	2000-08-21	Transkaryotic Therapies Inc	Protein production and protein delivery
US5798246A (en) *	1996-03-25	1998-08-25	Incyte Pharmaceuticals, Inc.	Cyclic nucleotide phosphodiesterase

1997
- 1997-10-16 US US08/951,648 patent/US5932465A/en not_active Expired - Fee Related
1998
- 1998-10-16 IL IL13028798A patent/IL130287A0/xx not_active IP Right Cessation
- 1998-10-16 JP JP52275099A patent/JP2001512327A/ja not_active Withdrawn
- 1998-10-16 CN CNB988025817A patent/CN1229499C/zh not_active Expired - Fee Related
- 1998-10-16 CN CNA2005101137657A patent/CN1800399A/zh active Pending
- 1998-10-16 RU RU99115892/13A patent/RU2272841C2/ru not_active IP Right Cessation
- 1998-10-16 EP EP05009465A patent/EP1571216A3/de not_active Withdrawn
- 1998-10-16 AU AU10974/99A patent/AU1097499A/en not_active Abandoned
- 1998-10-16 US US09/174,437 patent/US6133007A/en not_active Expired - Fee Related
- 1998-10-16 DE DE69830143T patent/DE69830143T2/de not_active Revoked
- 1998-10-16 EP EP98953651A patent/EP0944725B1/de not_active Revoked
- 1998-10-16 CA CA002275135A patent/CA2275135A1/en not_active Abandoned
- 1998-10-16 WO PCT/US1998/021956 patent/WO1999019495A1/en not_active Application Discontinuation
- 1998-10-16 AT AT98953651T patent/ATE295423T1/de not_active IP Right Cessation
- 1998-10-16 BR BR9806318-9A patent/BR9806318A/pt not_active Application Discontinuation
- 1998-10-16 ES ES98953651T patent/ES2245485T3/es not_active Expired - Lifetime
1999
- 1999-06-03 IL IL130287A patent/IL130287A/en unknown
- 1999-06-15 NO NO992916A patent/NO992916L/no not_active Application Discontinuation
2000
- 2000-10-11 US US09/686,055 patent/US6566087B1/en not_active Expired - Fee Related
2003
- 2003-05-19 US US10/440,998 patent/US20030215919A1/en not_active Abandoned
2005
- 2005-11-21 RU RU2005136013/13A patent/RU2005136013A/ru unknown
2006
- 2006-05-17 IL IL175698A patent/IL175698A0/en unknown

Also Published As

Publication number	Publication date
EP0944725A1 (de)	1999-09-29
RU2005136013A (ru)	2007-05-27
DE69830143T2 (de)	2006-03-02
JP2001512327A (ja)	2001-08-21
IL130287A0 (en)	2000-06-01
NO992916L (no)	1999-08-06
CN1800399A (zh)	2006-07-12
EP1571216A3 (de)	2006-04-26
US6133007A (en)	2000-10-17
CN1248291A (zh)	2000-03-22
RU2272841C2 (ru)	2006-03-27
NO992916D0 (no)	1999-06-15
EP1571216A2 (de)	2005-09-07
US6566087B1 (en)	2003-05-20
EP0944725B1 (de)	2005-05-11
US20030215919A1 (en)	2003-11-20
DE69830143D1 (en)	2005-06-16
ES2245485T3 (es)	2006-01-01
WO1999019495A1 (en)	1999-04-22
AU1097499A (en)	1999-05-03
BR9806318A (pt)	2000-03-14
CA2275135A1 (en)	1999-04-22
IL130287A (en)	2006-08-20
US5932465A (en)	1999-08-03
IL175698A0 (en)	2008-02-09
CN1229499C (zh)	2005-11-30

Publication	Publication Date	Title
IL175698A0 (en)	2008-02-09	Phosphodiesterase 8a
ITTO950367A0 (it)	1995-05-10	Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
NO20016243D0 (no)	2001-12-19	Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
ID19773A (id)	1998-07-30	Turunan-turunan 1,3,8-triaza-spiro (4,5) dekan-4-ona tersubtitusi-8
IL132496A0 (en)	2001-03-19	Mammalian cytokine-like factor 7
WO2000029574A3 (en)	2000-10-05	Inflammation-associated genes
WO1999042596A3 (en)	2000-03-02	Phosphodiesterase 10
ZA9710288B (en)	1998-05-15	Novel genes encoding telomerase proteins.
NO990666D0 (no)	1999-02-12	FremgangsmÕte for diversitets-kombinering, samt mottaker
DK0983363T3 (da)	2006-03-06	Phosphatidyl-3,4,5-triphosphat-afhængig proteinkinase
WO2000021986A3 (en)	2000-07-13	Matrix-remodeling genes
ATE234302T1 (de)	2003-03-15	Di- oder triazaspiro(4,5)decanderivate
WO1999009182A3 (en)	1999-05-20	Rab proteins
WO2000040722A3 (en)	2001-11-29	Insulin-synthesis genes
PE20399A1 (es)	1999-03-05	Muteina ob
WO1999029720A3 (en)	1999-08-26	Mammalian alpha helical protein-1
WO1998057986A3 (en)	1999-03-11	Human preprotachykinin b
AU7478098A (en)	1998-12-08	Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
WO1999043829A3 (en)	2000-01-06	Cell cycle related proteins
IT1291419B1 (it)	1999-01-11	Gruppo illuminante per l'illuminazione di acquari,terrari e simili.
WO2000014248A8 (en)	2000-10-05	Cyclic nucleotide-associated proteins
WO2000073450A3 (en)	2001-04-05	Cytoskeleton-associated proteins
WO1998055616A3 (en)	1999-03-04	Brca2 locus-associated protein
BR9708948A (pt)	1999-08-03	1,3 - Benzodioxois substituídos
WO1999042579A3 (en)	1999-10-14	Caf1-related protein

Legal Events

Date	Code	Title	Description
2006-04-15	UEP	Publication of translation of european patent specification	Ref document number: 0944725 Country of ref document: EP
2008-03-15	RZN	Patent revoked

Date

Code

Title

Description

2006-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0944725

Country of ref document: EP

2008-03-15

RZN

Patent revoked